CRISPR genome-wide screening identifies PAK1 as a critical driver of ARSI cross-resistance in prostate cancer progression
Article in Cancer Letters (February 2024)
The most recent citing publications are shown below. View all 48 publications that cite this research output on Dimensions.
Potential anticancer properties and mechanisms of thymoquinone in colorectal cancer
Article in Cancer Cell International (December 2023)
Identification of Balanol As a Potential Inhibitor of PAK1 That Induces Apoptosis and Cytoprotective Autophagy in Colorectal Cancer Cells
Article in ChemMedChem (July 2023)